Special Issue "Evaluation of New Molecules in Severe Infectious Diseases"
Deadline for manuscript submissions: 31 July 2021.
Interests: antibiotic resistance; antimicrobial peptides; quorum sensing inhibitor, infected wounds; wound healing; biofilm; Staphylococcal infections
Interests: peptides chemistry; antimicrobial peptides; enkephalinase inhibitors; lipopeptides; ESKAPE pathogens; Staphylococcus aureus; biofilm; toxicity; inflammatory bowel diseases
Hospital- and community-acquired Gram-positive and Gram-negative infections pose a substantial burden in terms of morbidity, mortality, and healthcare costs. The emergence of bacterial resistance to conventional antibiotics has become commonplace and heightened concern about the need for new drugs endowed with broader activity, which are useful in cases of infections unresponsive to common antimicrobial agents. Moreover, the introduction of new traditional antibiotics to counter these pathogens has frequently been closely followed by the emergence of resistant strains. For this reason, recent interest in the search for alternative therapeutics is growing, and it is becoming critical to identify effective agents to treat multidrug-resistant infections with novel mechanisms of activity.
Prof. Dr. Oriana Simonetti
Prof. Dr. Elżbieta Kamysz
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Antibiotic resistance
- In vitro susceptibility
- Antimicrobial peptides
- Quorum sensing inhibitors